Health
New staging system can inform treatment decisions for non-metastatic prostate cancer – News-Medical.Net
Doctors and biostatisticians at the University of Michigan Rogel Cancer Center have led the development and validation of a staging system to better predict outcomes…
Reviewed by Emily Henderson, B.Sc.Oct 23 2020
Doctors and biostatisticians at the University of Michigan Rogel Cancer Center have led the development and validation of a staging system to better predict outcomes and inform treatment decisions for men diagnosed with non-metastatic prostate cancer.
Although it is one of the most common cancers worldwide, prostate cancer remains one of the few major cancers for which the familiar, numerical staging system -; ranging from stage 1 to stage 4 -; has not…
-
General10 hours agoDreams shattered as 140 Zone RV caravan customers’ worst fears realised
-
General16 hours agoTaipei metro stabbing attack leaves at least three people dead after stabbing spree
-
General9 hours agoGrace Lillian Lee weaves a path from the Torres Strait to Paris
-
Noosa News20 hours agoCollapsed Queensland caravan maker Zone RV accused of trading insolvent